Researchers from Marshall University, the University of Washington, IRCCS Istituto Auxologico Italiano and the University of ...
Study expands the backing for sleep apnea-specific hypoxic burden ...
Pollinosis — an allergic reaction to pollen — was independently linked to an increased likelihood of having obstructive sleep apnea-hypopnea syndrome (OSAHS), and this association was stable despite ...
A million things could make you feel tired 24/7, but this underdiagnosed condition could be to blame.
Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points. (HealthDay News) — Tirzepatide reduces the apnea-hypopnea index (AHI) among ...
At World Sleep 2025, Robson Capasso, MD, of Stanford University in California, challenged the field's reliance on the apnea-hypopnea index (AHI) as the primary measure of treatment success in ...
Please provide your email address to receive an email when new articles are posted on . In an adjusted model, there was a significant link between long-term PM 10 exposure and apnea-hypopnea index.
Healthy foods like nuts, berries, and fatty fish may be able to help ease obstructive sleep apnea symptoms. However, alcohol, ...
Along with diet and exercise, sleep is the third pillar of health. And frankly, a good night's sleep is often the answer to whatever ails you. But for 30 million people in the United States, sleep ...
The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The ...
Mirroring results reported in a phase IIb study, Apnimed Inc.’s first of two pivotal trials testing AD-109 as an oral therapy in obstructive sleep apnea hit primary and secondary endpoints. Should ...